A detailed history of Banco Santander, S.A. transactions in Pfizer Inc stock. As of the latest transaction made, Banco Santander, S.A. holds 1,242,466 shares of PFE stock, worth $30.8 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
1,242,466
Previous 1,246,300 0.31%
Holding current value
$30.8 Million
Previous $34.9 Million 3.11%
% of portfolio
0.42%
Previous 0.43%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$27.7 - $31.39 $106,201 - $120,349
-3,834 Reduced 0.31%
1,242,466 $36 Million
Q2 2024

Jul 29, 2024

SELL
$25.26 - $29.6 $690,886 - $809,589
-27,351 Reduced 2.15%
1,246,300 $34.9 Million
Q1 2024

May 10, 2024

BUY
$25.89 - $29.73 $468,453 - $537,934
18,094 Added 1.44%
1,273,651 $35.3 Million
Q4 2023

Feb 09, 2024

BUY
$26.13 - $33.94 $8.69 Million - $11.3 Million
332,695 Added 36.05%
1,255,557 $36.1 Million
Q3 2023

Nov 08, 2023

BUY
$32.09 - $37.51 $4.38 Million - $5.12 Million
136,510 Added 17.36%
922,862 $30.6 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $3.74 Million - $4.33 Million
103,671 Added 15.19%
786,352 $28.8 Million
Q1 2023

May 10, 2023

BUY
$39.39 - $51.28 $8.79 Million - $11.4 Million
223,110 Added 48.55%
682,681 $27.9 Million
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $459,918 - $600,372
11,016 Added 2.46%
459,571 $23.6 Million
Q3 2022

Nov 08, 2022

SELL
$43.76 - $53.42 $397,559 - $485,320
-9,085 Reduced 1.99%
448,555 $19.6 Million
Q2 2022

Jul 28, 2022

BUY
$46.53 - $55.17 $6 Million - $7.12 Million
128,971 Added 39.24%
457,640 $24 Million
Q1 2022

May 09, 2022

BUY
$45.75 - $56.69 $1.14 Million - $1.41 Million
24,907 Added 8.2%
328,669 $17 Million
Q4 2021

Feb 09, 2022

BUY
$41.32 - $61.25 $2.45 Million - $3.63 Million
59,239 Added 24.23%
303,762 $17.9 Million
Q3 2021

Nov 08, 2021

SELL
$39.25 - $50.42 $7.58 Million - $9.74 Million
-193,160 Reduced 44.13%
244,523 $10.5 Million
Q2 2021

Jul 29, 2021

BUY
$35.91 - $40.68 $903,603 - $1.02 Million
25,163 Added 6.1%
437,683 $17.1 Million
Q1 2021

May 10, 2021

BUY
$33.49 - $37.77 $822,648 - $927,782
24,564 Added 6.33%
412,520 $14.9 Million
Q4 2020

Feb 12, 2021

SELL
$33.47 - $42.56 $4.58 Million - $5.82 Million
-136,770 Reduced 26.07%
387,956 $14.3 Million
Q3 2020

Nov 09, 2020

SELL
$31.75 - $37.25 $232,759 - $273,079
-7,331 Reduced 1.38%
524,726 $19.3 Million
Q2 2020

Aug 05, 2020

BUY
$30.12 - $36.54 $6.67 Million - $8.09 Million
221,463 Added 71.3%
532,057 $17.4 Million
Q1 2020

May 11, 2020

SELL
$27.03 - $38.62 $311,466 - $445,018
-11,523 Reduced 3.58%
310,594 $10.1 Million
Q4 2019

Feb 07, 2020

BUY
$32.92 - $37.36 $2.45 Million - $2.79 Million
74,561 Added 30.12%
322,117 $12.6 Million
Q3 2019

Nov 06, 2019

SELL
$32.49 - $42.13 $413,435 - $536,104
-12,725 Reduced 4.89%
247,556 $8.89 Million
Q2 2019

Aug 07, 2019

SELL
$36.98 - $41.52 $757,905 - $850,952
-20,495 Reduced 7.3%
260,281 $11.3 Million
Q1 2019

May 13, 2019

SELL
$37.5 - $41.2 $750,337 - $824,370
-20,009 Reduced 6.65%
280,776 $11.9 Million
Q4 2018

Feb 12, 2019

SELL
$38.47 - $43.86 $5.37 Million - $6.12 Million
-139,594 Reduced 31.7%
300,785 $13.1 Million
Q3 2018

Nov 13, 2018

BUY
$34.47 - $41.81 $4.38 Million - $5.31 Million
127,092 Added 40.57%
440,379 $19.4 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $2.18 Million - $2.32 Million
-66,035 Reduced 17.41%
313,287 $11.4 Million
Q1 2018

May 14, 2018

SELL
$31.91 - $37.02 $43 Million - $49.8 Million
-1,346,539 Reduced 78.02%
379,322 $13.5 Million
Q4 2017

Feb 14, 2018

BUY
$33.26 - $35.29 $53.7 Million - $57 Million
1,614,946 Added 1456.02%
1,725,861 $62.5 Million
Q3 2017

Nov 13, 2017

SELL
$31.0 - $34.15 $1.75 Million - $1.92 Million
-56,360 Reduced 33.69%
110,915 $3.95 Million
Q2 2017

Aug 11, 2017

BUY
N/A
167,275
167,275 $5.62 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $139B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Banco Santander, S.A. Portfolio

Follow Banco Santander, S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco Santander, S.A., based on Form 13F filings with the SEC.

News

Stay updated on Banco Santander, S.A. with notifications on news.